More First Electronic Product Information (ePI) for Human Medicines
More FDA issues draft Guidance on Confirmatory Evidence of Clinical Trials
More Further Warning Letters after Remote Evaluations by FDA
More China tightens Counterespionage Law - Risk for Audits and Inspections?
More FDA Warning Letter: Inadequate Testing of BZK and Many General GMP Violations
More Swissmedic Clarifies GMP Requirements for Formula Drugs
More Medical Cannabis - FDA's Perspective on Research and Drug Development
More FDA Delays Requirements for Cosmetic Facility Registration and Product Listing
More EMA: Q&A documents on the topic of "Centralised procedures" revised
More FDA Warning Letter: Lack of Identity Testing and Stability Program
More EMA launches Website for accelerating EU Clinical Trials
More EMA releases Youtube Videos of Workshop on Real World Data